AKT1 and breast carcinoma: Hollestelle et al. demonstrated that, among 40 human breast cancer cell lines, only one shows mutational activation of both PI3K/AKT and RAS/MAPK signaling pathways, suggesting that mutations of these pathways in breast cancer are mutually exclusive [31].